Year |
Citation |
Score |
2021 |
Pal Mudaranthakam D, Park M, Thompson J, Alsup AM, Krebill R, Chollet Hinton L, Hu J, Gajewski B, Godwin A, Mayo MS, Wick J, Harlan-Williams L, He J, Gurley-Calvez T. A framework for personalized mammogram screening. Preventive Medicine Reports. 23: 101446. PMID 34168953 DOI: 10.1016/j.pmedr.2021.101446 |
0.614 |
|
2021 |
Cernik C, Shergina E, Thompson J, Blackwell K, Stephens K, Kimminau KS, Wick J, Mayo MS, Gajewski B, He J, Mudaranthakam DP. Non-cancer clinical trials start-up metrics at an academic medical center: Implications for advancing research. Contemporary Clinical Trials Communications. 22: 100774. PMID 34027224 DOI: 10.1016/j.conctc.2021.100774 |
0.632 |
|
2018 |
Karanevich A, He J, Gajewski BJ. Using an Anchor to Improve Linear Predictions with Application to Predicting Disease Progression. Revista Colombiana De Estadistica. 41: 137-155. PMID 30686847 DOI: 10.15446/Rce.V41N2.68535 |
0.507 |
|
2018 |
Karanevich AG, Weisbrod LJ, Jawdat O, Barohn RJ, Gajewski BJ, He J, Statland JM. Using automated electronic medical record data extraction to model ALS survival and progression. Bmc Neurology. 18: 205. PMID 30547800 DOI: 10.1186/S12883-018-1208-Z |
0.496 |
|
2018 |
Karanevich AG, Statland JM, Gajewski BJ, He J. Using an onset-anchored Bayesian hierarchical model to improve predictions for amyotrophic lateral sclerosis disease progression. Bmc Medical Research Methodology. 18: 19. PMID 29409450 DOI: 10.1186/S12874-018-0479-9 |
0.5 |
|
2017 |
Jiang W, Wick JA, He J, Mahnken JD, Mayo MS. Bayesian design for two-arm randomized Phase II clinical trials with endpoints from the exponential family using multiple constraints. Journal of Biopharmaceutical Statistics. 1-16. PMID 29172970 DOI: 10.1080/10543406.2017.1402779 |
0.605 |
|
2016 |
Jiang W, Mahnken JD, He J, Mayo MS. Generalized optimal design for two-arm, randomized phase II clinical trials with endpoints from the exponential dispersion family. Pharmaceutical Statistics. PMID 27511063 DOI: 10.1002/Pst.1769 |
0.321 |
|
2016 |
Karanevich A, Statland J, Gajewski B, Barohn R, Koestler D, He J. Using onset-time to improve ALS disease progression predictions: A Bayesian hierarchical approach F1000research. 5. DOI: 10.7490/F1000Research.1113540.1 |
0.508 |
|
2013 |
Li Q, Fu GB, Zheng JT, He J, Niu XB, Chen QD, Yin Y, Qian X, Xu Q, Wang M, Sun AF, Shu Y, Rui H, Liu LZ, Jiang BH. NADPH oxidase subunit p22(phox)-mediated reactive oxygen species contribute to angiogenesis and tumor growth through AKT and ERK1/2 signaling pathways in prostate cancer. Biochimica Et Biophysica Acta. 1833: 3375-85. PMID 24113386 DOI: 10.1016/J.Bbamcr.2013.09.018 |
0.348 |
|
2013 |
He J, Niu X, Hu C, Zhang H, Guo Y, Ge Y, Wang G, Jiang Y. Expression and purification of recombinant NRL-Hsp90α and Cdc37-CRL proteins for in vitro Hsp90/Cdc37 inhibitors screening. Protein Expression and Purification. 92: 119-27. PMID 24056254 DOI: 10.1016/j.pep.2013.09.007 |
0.358 |
|
2013 |
Moriarty PM, Backes J, Dutton JA, He J, Ruisinger JF, Schmelzle K. Apple pectin for the reduction of niacin-induced flushing. Journal of Clinical Lipidology. 7: 140-6. PMID 23415433 DOI: 10.1016/J.Jacl.2012.11.005 |
0.314 |
|
2012 |
Pasnoor M, He J, Herbelin L, Dimachkie M, Barohn RJ. Phase II trial of methotrexate in myasthenia gravis. Annals of the New York Academy of Sciences. 1275: 23-8. PMID 23278574 DOI: 10.1111/J.1749-6632.2012.06804.X |
0.303 |
|
2012 |
He J, Mayo MS. Adjusted Interim Survival Analysis Under Nonproportional Hazards Communications in Statistics - Simulation and Computation. 41: 111-124. DOI: 10.1080/03610918.2011.582562 |
0.321 |
|
2011 |
He J. Modeling the dynamic association of BMI and mortality in the Framingham Heart Study. Annals of Epidemiology. 21: 517-25. PMID 21641526 DOI: 10.1016/J.Annepidem.2011.04.001 |
0.302 |
|
2010 |
He J, McGee DL, Niu X. Application of the Bayesian dynamic survival model in medicine. Statistics in Medicine. 29: 347-60. PMID 20014356 DOI: 10.1002/Sim.3795 |
0.471 |
|
2009 |
He J, McGee D, Niu X, Choi W. Examining the dynamic association of BMI and mortality in the Framingham Heart Study. International Journal of Environmental Research and Public Health. 6: 3115-26. PMID 20049250 DOI: 10.3390/Ijerph6123115 |
0.445 |
|
2008 |
Huang X, He J, Niu X, Menzel KD, Dahse HM, Grabley S, Fiedler HP, Sattler I, Hertweck C. Benzopyrenomycin, a cytotoxic bacterial polyketide metabolite with a benzo[a]pyrene-type carbocyclic ring system. Angewandte Chemie (International Ed. in English). 47: 3995-8. PMID 18412200 DOI: 10.1002/Anie.200800083 |
0.329 |
|
Show low-probability matches. |